Table 2.
Independent predictors of patients being treated with induction therapy
| Predictor | Odds ratio | Upper 95% CI | Lower 95% CI | p-value |
|---|---|---|---|---|
| Age (per decade) | 0.74 | 0.71 | 0.78 | <0.001 |
| Female sex | 0.79 | 0.69 | 0.90 | 0.001 |
| Race (ref = White) | ||||
| Black | 1.00 | 0.77 | 1.28 | 0.97 |
| Other | 0.75 | 0.52 | 1.08 | 0.12 |
| Charlson/Deyo comorbidity (ref = 0) | ||||
| 1 | 0.81 | 0.72 | 0.91 | <0.001 |
| ≥2 | 0.54 | 0.44 | 0.67 | <0.001 |
| Education above median | 1.01 | 0.90 | 1.13 | 0.85 |
| Income above median | 1.01 | 0.90 | 1.14 | 0.87 |
| Clinical T stage | ||||
| T2 | 4.38 | 3.79 | 5.05 | <0.001 |
| T3 | 9.86 | 8.61 | 11.29 | <0.001 |
| Clinical N+ | 2.15 | 1.95 | 2.37 | <0.001 |
| Squamous pathology (ref = Adenocarcinoma) | 1.07 | 0.93 | 1.24 | 0.35 |
| Academic/Research Facility (ref = Community) | 0.70 | 0.63 | 0.78 | <0.001 |
| Facility volume (per 5 cases) | 1.01 | 1.00 | 1.02 | 0.012 |